Tuberculosis (TB) remains a significant global health challenge, necessitating innovative
approaches for effective treatment. Conventional TB therapy encounters several limitations …

From the early sixteenth and seventeenth centuries to the present day of life, tuberculosis
(TB) still is a global health threat with some new emergence of resistance. This type of …

In spite of advances in tuberculosis (TB) chemotherapy, TB is still airborne deadly disorder
as a major issue of health concern worldwide today. Extensive researches have been …

The advances in the development of drugs and vaccines for major infectious diseases of
tuberculosis (TB), malaria and HIV represent some of the most significant milestones in their …

A new modality of drug targeting to tumors has been proposed. The ligand-mediated
approach, that already increases the therapeutic index of the drug, can still be optimized by …

Liposomes, lipid-based vesicular systems, have attracted major interest as a means to
improve drug delivery to various organs and tissues in the human body. Recent literature …

Inhaled drug delivery is a promising approach to achieving high lung drug concentrations to
facilitate efficient treatment of tuberculosis (TB) and to reduce the overall duration of …

Human gut is in permanent contact with microorganisms that play an important role in many
physiological processes including metabolism and immunologic activity. These …

The present study aimed to develop lipid–polymer hybrid nanoparticles (LPNs) for the
combined pulmonary delivery of isoniazid (INH) and ciprofloxacin hydrochloride (CIP HCl) …

Aim The present study was conducted to formulate and investigate liposomes for the dual
drug delivery based on anti-tubercular drug (s) combination ie Isoniazid (INH) and …